Dennis Mulroy Anaptysbio, Inc (ANAB) insider trading activity

ANAB Quotes by TradingView

Dennis Mulroy is CHIEF FINANCIAL OFFICER of ANAPTYSBIO, INC. Currently has a direct ownership of 21,852 shares of ANAB, which is worth approximately $739,034. The most recent transaction as insider was on Jan 08, 2026, when has been sold 2,515 shares (Common Stock) at a price of $44.71 per share, resulting in proceeds of $112,445. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.9K
58.32% 3M change
58.32% 12M change
Total Value Held $739,034

DENNIS MULROY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 08 2026
SELL
Open market or private sale
$112,445 $44.71 p/Share
2,515 Reduced 10.32%
21,852 Common Stock
Jan 07 2026
SELL
Open market or private sale
$86,069 $45.11 p/Share
1,908 Reduced 9.75%
17,667 Common Stock
Jan 07 2026
BUY
Exercise of conversion of derivative security
-
6,700 Added 21.57%
24,367 Common Stock
Jan 06 2026
BUY
Exercise of conversion of derivative security
-
5,245 Added 21.13%
19,575 Common Stock
Jan 05 2026
SELL
Open market or private sale
$145,483 $43.26 p/Share
3,363 Reduced 19.01%
14,330 Common Stock
Jan 03 2026
BUY
Exercise of conversion of derivative security
-
8,292 Added 31.91%
17,693 Common Stock
Dec 22 2025
SELL
Open market or private sale
$500,000 $50.0 p/Share
10,000 Reduced 51.54%
9,401 Common Stock
Dec 22 2025
BUY
Exercise of conversion of derivative security
$201,600 $20.16 p/Share
10,000 Added 34.01%
19,401 Common Stock
Dec 16 2025
SELL
Open market or private sale
$706,209 $44.91 p/Share
15,725 Reduced 62.58%
9,401 Common Stock
Dec 16 2025
BUY
Exercise of conversion of derivative security
$201,600 $20.16 p/Share
10,000 Added 28.47%
25,126 Common Stock
Jan 06 2025
SELL
Payment of exercise price or tax liability
$31,426 $15.3 p/Share
2,054 Reduced 12.95%
13,802 Common Stock
Jan 06 2025
BUY
Exercise of conversion of derivative security
-
5,245 Added 24.86%
15,856 Common Stock
Jan 03 2025
SELL
Payment of exercise price or tax liability
$49,742 $14.6 p/Share
3,407 Reduced 24.3%
10,611 Common Stock
Jan 03 2025
BUY
Exercise of conversion of derivative security
-
8,293 Added 37.17%
14,018 Common Stock
Sep 16 2024
SELL
Open market or private sale
$483,056 $39.53 p/Share
12,220 Reduced 72.03%
4,744 Common Stock
Sep 16 2024
BUY
Exercise of conversion of derivative security
$201,600 $20.16 p/Share
10,000 Added 40.41%
14,744 Common Stock
Sep 14 2024
BUY
Exercise of conversion of derivative security
-
6,000 Added 46.28%
6,964 Common Stock
May 22 2024
SELL
Open market or private sale
$35,580 $23.72 p/Share
1,500 Reduced 60.88%
964 Common Stock
Jan 30 2024
SELL
Open market or private sale
$72,425 $23.63 p/Share
3,065 Reduced 76.07%
964 Common Stock
Jan 08 2024
SELL
Open market or private sale
$47,545 $21.81 p/Share
2,180 Reduced 35.11%
4,029 Common Stock
Jan 06 2024
BUY
Exercise of conversion of derivative security
-
5,245 Added 45.79%
6,209 Common Stock
Sep 18 2023
SELL
Open market or private sale
$75,251 $19.32 p/Share
3,895 Reduced 80.16%
964 Common Stock
Sep 14 2023
SELL
Open market or private sale
$41,005 $19.48 p/Share
2,105 Reduced 30.23%
4,859 Common Stock
Sep 14 2023
BUY
Exercise of conversion of derivative security
-
6,000 Added 46.28%
6,964 Common Stock
Nov 15 2021
BUY
Grant, award, or other acquisition
$21,237 $22.03 p/Share
964 Added 50.0%
964 Common Stock
DM

Dennis Mulroy

CHIEF FINANCIAL OFFICER
San Diego, CA

Track Institutional and Insider Activities on ANAB

Follow ANAPTYSBIO, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANAB shares.

Notify only if

Insider Trading

Get notified when an Anaptysbio, Inc insider buys or sells ANAB shares.

Notify only if

News

Receive news related to ANAPTYSBIO, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ANAB